Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An observational, cross-sectional, multicenter study assessing the quality of life (QoL) and health care resource utilization of patients being prescribed with sacubitril/valsartan in Portugal

Next Previous
Trial Profile

An observational, cross-sectional, multicenter study assessing the quality of life (QoL) and health care resource utilization of patients being prescribed with sacubitril/valsartan in Portugal

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Nov 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sacubitril/valsartan (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms PRiMe

    • Most Recent Events

    • 19 Nov 2020 Results (n=285; as of July 2020) assessing persistence of sacubitril/valsartan in a real-world setting of heart failure (HF) patients at 12 months, presented at the 23rd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research.
    • 06 Nov 2019 Results (n=262; as of May 2019) assessing the prescription patterns and titration of Sacubitril/Valsarta were presented at the 22nd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
    • 06 Nov 2019 Results assessing the robustness of self-assessed NYHA by correlating it with patients HF symptoms presented at the 22nd Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top